about
IL-1β at the crossroad between rheumatoid arthritis and type 2 diabetes: may we kill two birds with one stone?Efficacy of inhibition of IL-1 in patients with rheumatoid arthritis and type 2 diabetes mellitus: two case reports and review of the literatureAdult-onset Still's disease: evaluation of prognostic tools and validation of the systemic score by analysis of 100 cases from three centersSearching for a good model for systemic sclerosis: the molecular profile and vascular changes occurring in UCD-200 chickens strongly resemble the early phase of human systemic sclerosis.The Endothelial-mesenchymal Transition in Systemic Sclerosis Is Induced by Endothelin-1 and Transforming Growth Factor-β and May Be Blocked by Macitentan, a Dual Endothelin-1 Receptor Antagonist.Glucocorticoids in rheumatoid arthritis: the silent companion in the therapeutic strategySevere COVID-19 and related hyperferritinaemia: more than an innocent bystander?
P50
Q30251741-CB969D4A-6A9E-4BFD-86AF-7B0948968BD7Q35687532-23377C9F-E43F-4D07-8BF5-A1567A2867D1Q36208563-63CDBE48-298D-4C86-94B3-B82AE23A376CQ42416370-EF6642E2-5070-4CE8-91F2-711C80E89414Q50945605-B6A953BC-88A0-4200-AFD2-0D0ACE594A0AQ95331027-150A58F1-AFF4-4084-87FA-35411A42C4D7Q95336155-8DB0869D-82AC-4252-819F-DE36E3640825
P50
description
wetenschapper
@nl
name
Onorina Berardicurti
@en
Onorina Berardicurti
@nl
type
label
Onorina Berardicurti
@en
Onorina Berardicurti
@nl
prefLabel
Onorina Berardicurti
@en
Onorina Berardicurti
@nl
P31
P496
0000-0002-2808-1581